Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia (Q28257174)
scientific article
Language:
(P31) (Q13442814)
(P304) 4110-6
(P407) (Q1860)
(P433) 18
(P478) 23
(P577) Monday, June 20, 2005
(P921) (Q974135)
(Q6934595)
(Q79460)
(Q29496)
(Q264118)
(Q422248)
(P1433) (Q400292)
(P1476) "Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia" (language: en)
(P2093) Eric J Feldman
Joseph Brandwein
Richard Stone
Matt Kalaycio
Joseph Moore
Julie O'Connor
Nancy Wedel
Gail J Roboz
Carole Miller
Raj Chopra
Joseph C Jurcic
Randy Brown
W Christopher Ehmann
Philip Schulman
Stanley R Frankel
Daniel De Angelo
David Scheinberg
other details
description scientific article

External Links